BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: He FL, Wang L, Zhao HW, Fan ZH, Zhao MF, Dai S, Yue ZD, Liu FQ. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. World J Gastroenterol 2015; 21(8): 2413-2418 [PMID: 25741149 DOI: 10.3748/wjg.v21.i8.2413]
URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2413.htm
Number Citing Articles
1
Gauri Mukhiya, Xueliang Zhou, Xinwei Han, Dechao Jiao, Gaurab Pokhrel, Yahua Li, Sita Pokhrel. Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysisScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-20399-x
2
Fuliang He, Hongwei Zhao, Shan Dai, Yingfeng Wu, Lei Wang, Hongdong Huang, Zhendong Yue, Zhenhua Fan, Xiaoqun Dong, Fuquan Liu. Transjugular intrahepatic portosystemic shunt for Budd–Chiari syndrome with diffuse occlusion of hepatic veinsScientific Reports 2016; 6(1) doi: 10.1038/srep36380
3
Yashwant Patidar, Chandan Kumar Pal, Amar Mukund, Guresh Kumar, Shiv Kumar Sarin. Retrospective comparative study of efficacy, safety and outcome of percutaneous intervention for Budd-Chiari syndrome patients with bilirubin less than 3 and 3–6 mg/dlThe British Journal of Radiology 2021; 94(1120) doi: 10.1259/bjr.20201157
4
Bin Qiu, Meng-Fei Zhao, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Shan Dai, Jian-Nan Yao, Fu-Quan Liu. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertensionWorld Journal of Gastroenterology 2015; 21(43): 12439-12447 doi: 10.3748/wjg.v21.i43.12439
5
Suprabhat Giri, Aditya Kale, Akash Shukla. Efficacy and Safety of Transjugular Intrahepatic Portosystemic Shunt Creation for Budd-Chiari Syndrome: A Systematic Review and Meta-AnalysisJournal of Vascular and Interventional Radiology 2022; 33(11): 1301 doi: 10.1016/j.jvir.2022.07.022
6
Thomas Reiberger, Andreas Püspök, Maria Schoder, Franziska Baumann-Durchschein, Theresa Bucsics, Christian Datz, Werner Dolak, Arnulf Ferlitsch, Armin Finkenstedt, Ivo Graziadei, Stephanie Hametner, Franz Karnel, Elisabeth Krones, Andreas Maieron, Mattias Mandorfer, Markus Peck-Radosavljevic, Florian Rainer, Philipp Schwabl, Vanessa Stadlbauer, Rudolf Stauber, Herbert Tilg, Michael Trauner, Heinz Zoller, Rainer Schöfl, Peter Fickert. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)Wiener klinische Wochenschrift 2017; 129(S3): 135 doi: 10.1007/s00508-017-1262-3
7
Mariana Oliveira Amarante MORENO, Cláudio Luiz da Silva Lima PAZ, Maria Gabriela Fernandes DEZAN, Lourianne Nascimento CAVALCANTE, Andre Castro LYRA. TEN-YEAR OUTCOMES OF TIPS FOR BUDD-CHIARI SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSISArquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-171
8
Varun Bansal, Pankaj Gupta, Saroj Sinha, Narender Dhaka, Naveen Kalra, Rajesh Vijayvergiya, Usha Dutta, Rakesh Kochhar. Budd-Chiari syndrome: imaging reviewThe British Journal of Radiology 2018; 91(1092) doi: 10.1259/bjr.20180441
9
Gabriel M. Knight, Jeffrey Clark, Justin R. Boike, Haripriya Maddur, Daniel R. Ganger, Abhinav Talwar, Ahsun Riaz, Kush Desai, Samdeep Mouli, Elias Hohlastos, Juan‐Carlos Garcia Pagan, Ahmed Gabr, Brady Stein, Robert Lewandowski, Bartley Thornburg, Riad Salem. TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard‐of‐Care TherapyHepatology 2021; 74(5): 2735 doi: 10.1002/hep.31915
10
Dhiraj Tripathi, Lawrence Sunderraj, Vishwaraj Vemala, Homoyon Mehrzad, Zergham Zia, Kamarjit Mangat, Richard West, Frederick Chen, Elwyn Elias, Simon P Olliff. Long‐term outcomes following percutaneous hepatic vein recanalization for Budd–Chiari syndromeLiver International 2017; 37(1): 111 doi: 10.1111/liv.13180
11
Andrea Mancuso. Timing of treatment and outcome of Budd-Chiari syndromeThe British Journal of Radiology 2022; 95(1136) doi: 10.1259/bjr.20210284